§2672. Availability of investigational drug, biological product or device by manufacturer
A manufacturer of an investigational drug, biological product or device may make available the investigational drug, biological product or device to an eligible patient. [PL 2015, c. 418, §1 (NEW).]
1. Compensation. A manufacturer may provide an investigational drug, biological product or device to an eligible patient with or without receiving compensation.
[PL 2015, c. 418, §1 (NEW).]
2. Costs. A manufacturer may require an eligible patient to pay the costs of manufacturing the dosage of an investigational drug, a biological product or a device dispensed to that eligible patient.
[PL 2015, c. 418, §1 (NEW).]
SECTION HISTORY
PL 2015, c. 418, §1 (NEW).
Structure Maine Revised Statutes
Chapter 602-A: ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS
22 §2672. Availability of investigational drug, biological product or device by manufacturer
22 §2673. Action against health care practitioner or health care provider license prohibited
22 §2674. Officials, employees and agents of the State
22 §2675. No cause of action created
22 §2676. Clinical trial coverage
22 §2677. Optional participation of health care practitioners and providers